DOORS: A Research Study to Understand How Oral Semaglutide Works in People With Type 2 Diabetes Who Change From Dipeptidyl Peptidase-4 Inhibitor (DPP4i) Treatment to Oral Semaglutide in Italy
Clinical trial NCT05755360 · COMPLETED
Trial details
- NCT number
- NCT05755360
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-02-21
- Primary completion
- 2024-10-21
- Enrollment
- 291
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.